1/18/2021USTR Unleashes 2020 Report for China's WTO Compliance Highlighting IP ...

1/18/2021Top JPMorgan Banker Sees Steady Supply of Chinese Health Care IPOs, Ev...

1/15/2021CDE Issues the Technical Guidelines for Quality Studies of TCM New Dru...

1/15/2021Innovent's sNDA for Sintilimab as Second-line Therapy for Squamous NSC...

1/15/2021CDE Issues the Technical Guidelines for Image Evaluation Procedures an...

1/15/2021JPO Issues Bidding Documents for the Fourth Batch of VBP

1/15/2021Recent Executive Moves

1/14/2021NHSA Highlights Ten Major Tasks in 2021

1/14/2021Chiome and Henlius Sign Greater China Licensing Deal for Anti-TPOR-2 A...

1/14/2021EOC Pharma Licenses Aadi Bioscience's mTOR Inhibitor in Greater China

1/14/2021China Officially Bans Phenolphthalein Tablets and Lozenges Due to Seri...

1/14/2021Reform Has Unleashed Chinese Drugs Innovation Boom, Though Some Pharma...

1/14/2021What Do Novartis Deal, PD-1 Competition In China Mean For Tislelizumab...

1/14/2021Pharma Companies to Cut Prices of News Drugs by 51% to Access Chinese ...

1/14/2021Novartis, Once Wary of Chinese M&A, Dives into BeiGene's Cancer Immuno...

1/13/2021NMPA Issues the Measures for Post Marketing Changes of Drug Products

1/13/2021Domestic PD-1s in the 2020 NRDL Negotiated Entry: Winners Take All

1/13/2021PharmCube: Top 15 Innovative Drug In-licensing Deals by Chinese Pharma...

1/13/2021Sesen Bio and Qilu Pharma Announce Acceptance IND for Vicineum  in C...

1/13/2021BeiGene Granted Chinese Approval of Tislelizumab in Combo with Chemoth...

1/13/2021Gracell Approved to Begin Phase 1/2 Trial of CAR-T GC007g for Leukem...

1/12/2021Qilian International Debuts on Nasdaq

1/12/2021Swiss Re Sees Short-term Health insurance as Growth Driver in China

1/11/2021VISEN Pharma Closes $150M Series B Financing for Novel Endocrinology D...

1/11/2021Novartis and BeiGene in $2.2B Deal Latter's Promising Checkpoint Inhi...

1/11/2021Chi-Med and Inmagene Announce Partnership for Portfolio of Drug Candi...

1/11/2021Strand Therapeutics and BeiGene Enter into Agreement to Develop Solid ...

1/11/2021Chipscreen Files Pivotal PIII Trial IND Submission for Anticancer Chia...

1/11/2021NHSA Issues Two Interim Rules for Management of BMI Designated Medical...

1/8/2021VISEN Pharma Granted IND Approval for P2 Trial of Achondroplasia Drug...

Page:148/719 Total number of articles:21555: [First][<<] [146] [147] [148] [149] [150] [>>] [End]